PRTA (STOCKS)
Prothena Corporation plc Ordinary Shares
$9.080000
-0.180000 (-1.94%)
Prev close: $9.260000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Gene G. Kinney
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $517.61M
- Employees
- 163
- P/E (TTM)
- -11.14
- P/B (TTM)
- 1.67
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $54.53M |
| Benefits Costs and Expenses | $98.88M |
| Costs And Expenses | $98.88M |
| Nonoperating Income/Loss | $11.16M |
| Operating Expenses | $110.04M |
| Research and Development | $64.95M |
| Other Operating Expenses | $45.09M |
| Operating Income/Loss | -$55.51M |
| Income/Loss From Continuing Operations After Tax | -$43.99M |
| Income/Loss From Continuing Operations Before Tax | -$44.35M |
| Income Tax Expense/Benefit | -$358.00K |
| Interest Income/Expense After Provision For Losses | $10.97M |
| Interest Income/Expense Operating, Net | $10.97M |
| Net Income/Loss | -$43.99M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$43.99M |
| Net Income/Loss Available To Common Stockholders, Basic | -$43.99M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Provision For Loan, Lease, And Other Losses | $0.00 |
| Basic Earnings Per Share | -$0.83 |
| Diluted Earnings Per Share | -$0.84 |
| Basic Average Shares | 106,753,000 |
| Diluted Average Shares | 107,256,000 |
| Assets | $302.58M |
| Current Assets | $292.01M |
| Noncurrent Assets | $10.57M |
| Fixed Assets | $2.49M |
| Other Non-current Assets | $8.08M |
| Liabilities | $15.69M |
| Current Liabilities | $11.66M |
| Accounts Payable | $1.94M |
| Wages | $4.48M |
| Other Current Liabilities | $5.24M |
| Noncurrent Liabilities | $4.03M |
| Equity | $286.89M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $286.89M |
| Liabilities And Equity | $302.58M |
| Net Cash Flow From Operating Activities | -$60.05M |
| Net Cash Flow From Operating Activities, Continuing | -$60.05M |
| Net Cash Flow From Investing Activities | -$662.00K |
| Net Cash Flow From Investing Activities, Continuing | -$662.00K |
| Net Cash Flow From Financing Activities | -$22.53M |
| Net Cash Flow From Financing Activities, Continuing | -$22.53M |
| Net Cash Flow | -$83.24M |
| Net Cash Flow, Continuing | -$83.24M |
| Comprehensive Income/Loss | -$43.99M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$43.99M |
| Other Comprehensive Income/Loss | $0.00 |